Hinge Health, INC Form 4 insider transactions

Insight Holdings Group, LLC and affiliated entities reported transactions involving Hinge Health, Inc. Class A and Class B common stock on June 16, 2026.

Director Elliott Robinson reports the sale of Hinge Health Class A Common Stock by Bessemer Venture Partners funds.

Executive Chairman Gabriel Mecklenburg executed a pre-planned sale of 50,000 shares of Hinge Health Class A Common Stock.

Director Kristina M. Leslie acquired 3,837 restricted stock units as part of Hinge Health's non-employee director compensation program.

Director Elliott Robinson reports the sale of Hinge Health Class A Common Stock by Bessemer Venture Partners funds.

Hinge Health's Exec. Chairman & Co-Founder, Gabriel Mecklenburg, reported the sale of Class A Common Stock valued between $55.21 and $62.07 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

CFO James Budge disposed of 9,986 shares of Hinge Health Class A Common Stock to satisfy tax withholding obligations.

Hinge Health President James Pursley disposed of 6,326 shares of Class A Common Stock to cover tax withholding obligations.

Hinge Health CFO James Budge sold 5,907 shares of Class A Common Stock on May 26, 2026, pursuant to a Rule 10b5-1 trading plan.

Hinge Health President James Pursley sold 16,000 shares of Class A Common Stock via a pre-arranged 10b5-1 trading plan.

Hinge Health Executive Chairman and Co-Founder Gabriel Mecklenburg sold 83,333 shares of Class A Common Stock via a Rule 10b5-1 trading plan.

Hinge Health's Chief Financial Officer, James Budge, reported a sale of Class A Common Stock executed under a pre-arranged trading plan.

Hinge Health President James Pursley acquired 65,000 restricted stock units as part of an exempt company award.

Hinge Health CFO James Budge was granted 65,000 restricted stock units as part of an exempt equity award.

Hinge Health, Inc. CFO James Budge reported the sale of Class A Common Stock under a pre-arranged trading plan.

Director Elliott Robinson reports the sale of Hinge Health Class A Common Stock by Bessemer Venture Partners funds.

Executive Chairman Gabriel Mecklenburg sold 50,000 shares of Hinge Health Class A Common Stock via a Rule 10b5-1 trading plan.

CEO and Co-Founder Daniel Antonio Perez reported the sale of 150,000 shares of Class A Common Stock via a Rule 10b5-1 trading plan.

Hinge Health President James Pursley reported a transaction involving the sale of Class A Common Stock.

Hinge Health, Inc. Chief Financial Officer, James Budge, reported a transaction involving Class A Common Stock on May 1, 2026.

Hinge Health's Exec Chairman and Co-Founder, Gabriel Mecklenburg, sold 33,333 shares of Class A Common Stock for approximately $45.04 per share under a pre-arranged 10b5-1 trading plan.

Tyler Sloat, a Director at Hinge Health, Inc., acquired 68 shares of Class A Common Stock through the settlement of vested RSUs on April 5, 2026.

Hinge Health's Exec. Chairman & Co-Founder, Gabriel Mecklenburg, reported transactions involving Class A Common Stock, including acquisitions and dispositions under a Rule 10b5-1 trading plan.

Hinge Health President James Pursley disposed of 831 Class A Common Stock shares on April 1, 2026, to cover tax withholding obligations related to restricted stock unit vesting.

Hinge Health's Chief Financial Officer, James Budge, disposed of 4,614 Class A Common Stock shares on April 1, 2026, to cover tax liabilities from vested restricted stock units.

Hinge Health's CFO, James Budge, sold a total of 11,006 shares of Class A Common Stock on March 23, 2026, under a pre-arranged 10b5-1 trading plan.

Hinge Health President James Pursley sold 15,000 shares of Class A Common Stock for over $630,000 through a pre-arranged trading plan.

Hinge Health's President, James Pursley, reported a disposition of 5,127 Class A Common Stock shares for tax withholding related to RSU vesting.

Hinge Health CFO James Budge disposed of 7,699 Class A Common Stock shares to cover tax liabilities from RSU vesting.

Hinge Health President James Pursley sold 15,000 shares of Class A Common Stock for approximately $590,000 through a pre-arranged 10b5-1 trading plan.